NextCure, Inc. - NXTC
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 05, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| Feb 17, 2026 | SCHEDULE 13G | Ikarian Capital, LLC | 9.99% | 363,035 | View |
| Feb 17, 2026 | SCHEDULE 13G | Neil Shahrestani | 9.99% | 363,035 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Master Fund LP | 9.9% | 271,127 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Squadron Capital Management LLC | 9.9% | 271,127 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Matthew Sesterhenn | 9.9% | 271,127 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | William Blank | 9.9% | 271,127 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Pfizer Inc. (IRS Identification No.: 13-5315170) | 3.0% | 157,646 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Pfizer Ventures (US) LLC (IRS Indentification No. 82-5524518 ) | 2.5% | 131,109 | View |
| Feb 12, 2026 | SCHEDULE 13G | SilverArc Capital Management, LLC | 5.02% | 176,057 | View |
| Feb 12, 2026 | SCHEDULE 13G | Devesh Gandhi | 5.02% | 176,057 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 9.99% | 348,607 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Michael Cho | 9.99% | 348,607 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Affinity Healthcare Fund, LP | 7.17% | 191,882 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 7.17% | 191,882 | View |
| Oct 24, 2025 | SCHEDULE 13G | Squadron Master Fund LP | 5.8% | 154,021 | View |
| Oct 24, 2025 | SCHEDULE 13G | Squadron Capital Management LLC | 6.5% | 173,861 | View |
| Oct 24, 2025 | SCHEDULE 13G | Matthew Sesterhenn | 6.5% | 173,861 | View |
| Oct 24, 2025 | SCHEDULE 13G | William Blank | 6.5% | 173,861 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.